Guardant enters race for liquid biopsy with colon cancer study

Guardant enters race for liquid biopsy with colon cancer study

STAT Plus: Blood test maker Guardant enters race for liquid biopsy with colon cancer study

By MATTHEW HERPER

ANNIE CAVANAGH/WELLCOME

Guardant Health, whose study will include 10,000 patients, is being closely watched in the race to develop liquid biopsies.

READ MORE